▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #2744 by analyst upside · 2026-08-13
ADUS
Addus HomeCare Corporation
Healthcare · Market Cap $2B · P/E 20.5x
ANALYST PRICE TARGET
+14.1%
implied upside to consensus target
Current Price $118.06
Consensus Target $134.69
Bull Target $155.0
Bear Target $96.0
Analysts Covering 13
ANALYST CONSENSUS - BUY
Strong Buy
3
Buy
8
Hold
1
Sell
1
52-Week Low $87.95
52-Week High $124.44
YTD Return +10.8%
FUNDAMENTALS
Market Cap $2B
P/E Ratio (TTM) 20.5x
Forward P/E 15.7x
EPS (TTM) $5.77
PEG Ratio 1.13
Dividend Yield N/A
Revenue (TTM) $1.5B
Profit Margin 7.1%
52-WEEK RANGE
52-Week Low $87.95
52-Week High $124.44
Current Price $118.06
Bear Target $96.0
Bull Target $155.0
● Now $118.06 ● Target $134.69
TRADING DATA
Avg Volume 245K
YTD Return +10.8%
Analyst Count 13
Consensus Buy
Upside to Target +14.1%
Last Updated 2026-08-13

ANALYST SUMMARY

Addus HomeCare Corporation (ADUS) is currently trading at $118.06 with a Wall Street consensus price target of $134.69, implying potential upside of 14.1% over the next 12 months. 13 analysts currently cover ADUS, with a consensus rating of Buy - 85% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $155.0, while the most cautious has a target of $96.0.

ADUS operates in the Healthcare sector with a market capitalisation of $2B. The stock is up 10.8% year-to-date and is currently trading near the upper end of its 52-week range of $87.95 – $124.44.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

MD -1.3%
Pediatrix Medical Group, Inc.
$2B · P/E 12.7x · Hold
TMDX +11.8%
TransMedics Group, Inc.
$3B · P/E 23.1x · Buy
LMAT +33.9%
LeMaitre Vascular, Inc.
$2B · P/E 29.0x · Buy
HCSG +28.8%
Healthcare Services Group, Inc.
$1B · P/E 12.2x · Hold
CNMD -8.0%
CONMED Corporation
$1B · P/E 26.7x · Hold

RECENT ANALYST CALLS

Upgrade/downgrade history for ADUS, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Citizens reit
Market Outperform → Market Outperform 2026-05-18 Building track record
Barclays - Reiterated
Underweight → Underweight 2026-05-15 Building track record
Citizens - Reiterated
Market Outperform → Market Outperform 2026-05-06 Building track record
Barclays - Reiterated
Underweight → Underweight 2026-03-25 Building track record
Stephens & Co. - Reiterated
Overweight → Overweight 2026-02-25 Building track record
Barclays - Reiterated
Underweight → Underweight 2026-02-24 Building track record
BMO Capital ● Initiated
Market Perform 2025-11-13 Building track record
RBC Capital - Reiterated
Outperform → Outperform 2025-11-07 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
62
out of 100
Coverage depth
20/30
Consensus clarity
20/30
Vote unanimity
20/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →